0001562180-18-003130.txt : 20180629
0001562180-18-003130.hdr.sgml : 20180629
20180629162219
ACCESSION NUMBER: 0001562180-18-003130
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180627
FILED AS OF DATE: 20180629
DATE AS OF CHANGE: 20180629
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Robbins Andrew R
CENTRAL INDEX KEY: 0001590157
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-16633
FILM NUMBER: 18929546
MAIL ADDRESS:
STREET 1: C/O 3200 WALNUT ST
CITY: BOULDER
STATE: CO
ZIP: 80301
FORMER NAME:
FORMER CONFORMED NAME: Robbins Andrews R
DATE OF NAME CHANGE: 20131025
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ARRAY BIOPHARMA INC
CENTRAL INDEX KEY: 0001100412
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 841460811
STATE OF INCORPORATION: DE
FISCAL YEAR END: 0630
BUSINESS ADDRESS:
STREET 1: 3200 WALNUT STREET
CITY: BOULDER
STATE: CO
ZIP: 80301
BUSINESS PHONE: 3033816600
MAIL ADDRESS:
STREET 1: 3200 WALNUT STREET
CITY: BOULDER
STATE: CO
ZIP: 80301
4
1
primarydocument.xml
PRIMARY DOCUMENT
X0306
4
2018-06-27
false
0001100412
ARRAY BIOPHARMA INC
ARRY
0001590157
Robbins Andrew R
C/O ARRAY BIOPHARMA INC.
3200 WALNUT ST
BOULDER
CO
80301
false
true
false
false
COO
Common Stock
2018-06-27
4
M
false
32068.00
0.00
A
191535.00
D
Common Stock
2018-06-27
4
F
false
14104.00
18.50
D
177431.00
D
Common Stock
2018-06-27
4
S
false
17964.00
17.74
D
159467.00
D
Restricted Stock Units
0.00
2018-06-27
4
M
false
32068.00
0.00
D
2018-08-18
Common Stock
32068.00
0.00
D
Represents shares released on vesting of Restricted Stock Units ("RSUs") granted to the reporting person on August 18, 2014. The grant of these RSUs was previously reported on Table II.
Represents shares withheld to satisfy tax withholding obligations of the reporting person.
These trades were made pursuant to a Rule 10b5-1 trading plan.
The price reported for these shares is the weighted average sale price of transactions made at prices from $17.60 to $17.84. Details of actual prices for shares sold are available from the Issuer upon request.
RSUs representing 32,068 shares of common stock vested upon the achievement of a second milestone relating to the return of rights to binimetinib to the Issuer on or prior to the fourth anniversary of the grant date, subject to continued service with the Issuer as of the vesting date.
Jason Haddock, attorney-in-fact for Andrew R. Robbins
2018-06-29